Investors are feeling the pinch as MustGrow Biologics Corp. faces a downturn in its stock performance.
MustGrow Biologics Corp. (MGRO.V) is experiencing a decline in its stock price, dropping 2.27% today to close at CA$0.43. This marks a challenging session for the company, which has seen limited news to support its stock.
Investor takeaway: With a market cap of CA$30.98 million and no current dividend yield, investors should be cautious as MustGrow's recent performance raises questions about its growth trajectory.
Advertisement
MustGrow Biologics Corp.
MGRO.V
MGRO.V
MustGrow Biologics Corp.
WealthAwesomeMarket cap
$30.98M
52W high
$0.94
52W low
$0.29
1W change
+4.76%
Beta
0.41
Analyst Price Targets
Based on analyst covering MGRO · as of Sep 30, 2026
Wall Street analysts forecast MGRO stock price to rise 470.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.51
+470.5% Upside
Previously C$2.70 on Sep 17, 2026
Current Price
C$0.44
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MGRO's historical volatility
30-Day Vol
92.5%
Annualized
90-Day Vol
81.0%
Annualized
Trend (90d)
+40.0%
Annualized drift
90d Mean
C$0.51
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.46 | C$0.34 – C$0.64 |
| 60 trading days | C$0.48 | C$0.31 – C$0.76 |
| 90 trading days | C$0.51 | C$0.29 – C$0.88 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
MustGrow's stock down 2.27% today
The stock's decline reflects ongoing investor concerns about the company's financial health and growth prospects.
Bull case
If MustGrow can make the most of its recent partnerships and secure additional funding, it might stabilize and potentially bounce back in the future.
Bear case
The lack of significant news and a falling stock price could signal deeper issues within the company, leading to more skepticism from investors.
Current Market Performance
Advertisement
MustGrow Biologics Corp. is down 2.27% today, closing at CA$0.43. This decline raises concerns among investors, particularly given the company's small market cap of CA$30.98 million. The absence of recent positive developments or news may be contributing to this downward trend.
Investor Sentiment
With no recent announcements to inspire confidence, investors are left questioning the company's future. The recent appointment of a new officer and the completion of a financing round have not translated into positive stock performance, highlighting the volatility often associated with small-cap stocks like MGRO.V.
Looking Ahead
As MustGrow navigates this downturn, investors will be closely monitoring any developments that could impact its operational strategy or financial health. The company's ability to secure partnerships and funding will be crucial in regaining investor trust.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
